TABLE 2.

Patient Demographic Characteristics of Study Cohorts in the Pre-Intervention and Post-Intervention Periods (2020-2022)

Year	2020		2021		2022
Group	Treatment	Control	Treatment	Control	Treatment	Control
Unique patients, n	317,613	943,389	405,794	940,761	547,852	845,537
Diabetes	74,681	207,365	95,102	211,612	129,379	196,563
Hypertension	204,452	610,589	259,180	602,184	348,037	535,690
Cholesterol	218,962	666,615	289,792	678,650	399,487	613,452
Age (mean)	70.1	73.3	71.0	73.5	71.7	73.6
Sex, %
Female	57.0	56.1	56.3	56.2	55.3	56.2
Male	43.0	43.9	43.7	43.8	44.7	43.8
Urbanicity, %
Urban	10.0	10.6	8.9	10.4	8.2	11.6
Rural	35.6	33.6	39.5	34.0	42.8	32.5
Suburban	54.4	55.8	51.6	55.6	49.0	55.9
Median income, $	60,795	64,327	62,003	64,361	62,880	64,323